GlucoTrack, Inc. (GCTK )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol GCTK
- Company GlucoTrack, Inc.
- Price $0.29
- Changes Percentage 32.39
- Change 0.0718
- Day Low $0.22
- Day High $0.29
- Year High $4.95
- Year Low $0.2
- Market Cap $4,254,283
- Price Avg 50 EMA (D) $1.01
- Price Avg 200 EMA (D) $1.89
- Exchange NASDAQ
- Volume 408,777
- Average Volume 470,952
- Open $0.23
- Previous Close $0.22
- EPS -2.91
- PE -0.10
- Earnings Announcement 2024-11-12 05:00:00
- Shares Outstanding $14,495,000
Company brief: GLUCOTRACK, INC. (GCTK )
- Healthcare
- Medical - Instruments & Supplies
- Mr. Paul V. Goode Ph.D.
- https://www.glucotrack.com
- IL
- N/A
- 04-25-2013
- US45824Q5071
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.